Park Medi World Ltd

Park Medi World Limited announced that its Board of Directors approved the incorporation of a wholly-owned subsidiary, tentatively named “Park Medicity Prayagraj Limited” or “Park Hospital Prayagraj Limited,” as a Special Purpose Vehicle to develop and operate a 550-bed multi-super-speciality hospital in Prayagraj, Uttar Pradesh, under a Public-Private Partnership model awarded by the Prayagraj Municipal Corporation; the incorporation will involve a cash consideration of Rs 0.15 crore for 1,50,000 equity shares with a face value of Rs 10 each, and the company will hold 100% shareholding.

Park Medi World Limited announced August 31, 2026, that its Board of Directors approved the incorporation of a wholly-owned subsidiary, tentatively named “Park Medicity Prayagraj Limited” or “Park Hospital Prayagraj Limited,” as a Special Purpose Vehicle to develop and operate a 550-bed multi-super-speciality hospital in Prayagraj, Uttar Pradesh, under a Public-Private Partnership model awarded by the Prayagraj Municipal Corporation; the subsidiary will have an authorized capital of Rs 0.15 crore, comprising 150,000 equity shares with a face value of Rs 10 each, and the company will hold 100% shareholding.

Crisil Ratings Limited’s recent monitoring report reveals a significant delay in the utilization of proceeds from a debt issuance, as of August 1, 2026. Originally, the company planned to allocate Rs 229.59 million for medical equipment purchases, but only Rs 36.08 million has been utilized as of June 30, 2026, due to delays in procurement negotiations and delivery timelines. Consequently, Rs 648.32 million remains unutilized, held in monitoring accounts at Axis Bank and ICICI Bank, including Rs 72.32 million from a fresh issue and Rs 576.00 million from an Offer for Sale. The company intends to deploy the remaining funds in a subsequent period, and a general corporate purpose outlined in the original prospectus has been deemed "Not Applicable." The substantial delay and large unutilized balance raise concerns regarding the company's planning and execution capabilities.

Park Medi World Ltd share price rose by 5.12% to Rs 293.4 after the company's net profit registered a growth of 15.38% to Rs 88.59 crore, while revenue from operations improved marginally 3.32% to Rs 475.71 crore in Q2FY26 over Q1FY26. The market capitalization of Hospital industry group stocks on BSE stood at Rs 4.99 lakh crore, rising 3.87%. It has marginally improved by 0.45% over last one week and spiked sharply by 17.80% in last one month while the market capitalization of Park Medi World Ltd has inched up 5.09% and 22.63% in the same period respectively. Profit before tax (PBT) of Park Medi World Ltd stood at Rs 105.08 crore in Q2 FY26, surging by 28.30% year-on-year, and gaining 1.63% quarter-on-quarter. EBITDA came in at Rs 118 crore, jumping 20.78% YoY and declining 1.19% sequentially. Total expenses grew marginally by 5.11% to Rs 368.46 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 77.12 crore, marginally falling by 1.67% YoY, while employee benefits expense was at Rs 92.41 crore, registering a growth of 7.25% YoY. For the TTM ended FY26, revenue from operations improved 13.20% to Rs 1393.57 crore, while net profit jumped 41.73% to Rs 215.44 crore, compared to previous TTM. EBITDA jumped by 28361% to Rs 338.59 crore, and PBT soared 30.95% to Rs 285.67 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 215.38 crore in FY26, as against Rs 366.8 crore in FY25. Park Medi World Ltd surged by 98.04% in last one year, significantly outperforming the benchmark BSE Sensex which has softened by 3.81% during the same period.

Park Medi World Limited, a hospital chain operating as North India’s second largest, announced its unaudited financial results for the quarter ended June 30, 2026, reporting revenue of Rs 4,757 million, a 19% year-on-year increase, and net profit of Rs 886 million, up 35% year-on-year. The company, listed on the NSE as PARKHOSPS and BSE as 544645, commissioned its largest greenfield hospital in Panchkula with 350 beds and signed definitive agreements to acquire ‘The Medicity Hospital’ in Rudrapur for Rs 177 crore and ‘Mehar Hospital’ in Zirakpur for Rs 107 crore, with plans to commission a total of 1,490 beds in calendar year 2026.

Park Medi World Limited announced July 31, 2026, the successful acquisition of 80% of V3 Healthcare Private Limited, which operates The Medicity Hospital - Rudrapur, following a disclosure made on May 25, 2026; V3 Healthcare Private Limited has become a subsidiary of Park Medi World Limited, and the company plans to acquire the remaining 20% equity stake by April 30, 2030, with The Medicity Hospital - Rudrapur scheduled to launch on August 2, 2026.

Park Medi World Limited will hold a board meeting on August 3, 2026, to consider and approve the standalone and consolidated unaudited financial results for the quarter ended June 30, 2026, the company said in a filing with the BSE Limited and National Stock Exchange of India Limited. Trading window for designated persons and their immediate relatives will remain closed until the end of business hours on August 5, 2026.

Umkal Health Care, a wholly-owned subsidiary of Park Medi World, has today approved a significant expansion of its existing 225-bed Park Hospital in Palam Vihar, Gurugram, with the addition of 100 new beds. The Palam Vihar facility is one of the flagship hospitals of the group; in FY'26, it had an occupancy of ~86%, delivered a revenue of ~Rs 245 crore. The newly expanded facility will be branded Park Hospital Platinum and is slated to commence operations in November 2026. With this expansion, Park Group's consolidated bed capacity across Gurugram will rise to 750 beds.

The acquisition will be carried out through the purchase of V3 Healthcare, which operates The Medicity Hospital. The transaction will be completed in two phases, with 80% stake acquisition expected by 31 August 2026 and the remaining 20% by 30 April 2030. The Medicity Hospital is a 330-bed multi-super speciality hospital and is the largest hospital in the Kumaon region. The facility is NABH accredited and offers more than 20 specialities, including cardiology, neurosurgery, oncology, orthopaedics and nephrology. Park Medi World said the acquisition marks its entry into Uttarakhand and expands its presence to a sixth state. The company said the deal aligns with its strategy of expanding in high-potential and underserved healthcare markets. The target company reported unaudited turnover of Rs 55.74 crore in FY26 compared with Rs 49.04 crore in FY25 and Rs 42.46 crore in FY24. Park Group currently operates 16 hospitals with a combined capacity of 3,960 beds across North India. The group plans to add another 1,500 beds through ongoing expansion projects, taking total capacity to 5,790 beds by March 2028. On a consolidated basis, Park Medi World's net profit rose 58.03% to Rs 70.86 crore while net sales rose 30.09% to Rs 460.41 crore in Q4 March 2026 over Q4 March 2025. Powered by Capital Market - Live

Net profit of Park Medi World rose 58.03% to Rs 70.86 crore in the quarter ended March 2026 as against Rs 44.84 crore during the previous quarter ended March 2025. Sales rose 30.09% to Rs 460.41 crore in the quarter ended March 2026 as against Rs 353.92 crore during the previous quarter ended March 2025. For the full year,net profit rose 28.01% to Rs 258.12 crore in the year ended March 2026 as against Rs 201.64 crore during the previous year ended March 2025. Sales rose 20.51% to Rs 1679.36 crore in the year ended March 2026 as against Rs 1393.57 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales460.41353.92 30 1679.361393.57 21 OPM %27.6624.99 -26.4626.62 - PBDT120.9081.36 49 417.05342.57 22 PBT103.3965.83 57 354.58285.67 24 NP70.8644.84 58 258.12201.64 28 Powered by Capital Market - Live